Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR* D report

ME Thase, ES Friedman, MM Biggs… - American Journal of …, 2007 - Am Psychiatric Assoc
Objective: The authors compared the effectiveness of cognitive therapy and
pharmacotherapy as second-step strategies for outpatients with major depressive disorder …

Acceptability of second-step treatments to depressed outpatients: a STAR* D report

SR Wisniewski, M Fava, MH Trivedi… - American Journal of …, 2007 - Am Psychiatric Assoc
Objective: Treatment of major depressive disorder typically entails implementing treatments
in a stepwise fashion until a satisfactory outcome is achieved. This study sought to identify …

Benefits of sequentially adding cognitive-behavioral therapy or antidepressant medication for adults with nonremitting depression

BW Dunlop, D LoParo, B Kinkead… - American Journal of …, 2019 - Am Psychiatric Assoc
Objective: Adults with major depressive disorder frequently do not achieve remission with an
initial treatment. Addition of psychotherapy for patients who do not achieve remission with …

Sequenced treatment alternatives to relieve depression (STAR* D): rationale and design

AJ Rush, M Fava, SR Wisniewski, PW Lavori… - Controlled clinical …, 2004 - Elsevier
STAR* D is a multisite, prospective, randomized, multistep clinical trial of outpatients with
nonpsychotic major depressive disorder. The study compares various treatment options for …

Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features

AJ Rush, SR Wisniewski, D Warden… - Archives of general …, 2008 - jamanetwork.com
Context Little is known about selecting among second-step medications for major
depressive disorder after intolerance or lack of remission with an initial selective serotonin …

Prevention of relapse following cognitive therapy vs medications in moderate to severe depression

SD Hollon, RJ DeRubeis, RC Shelton… - Archives of general …, 2005 - jamanetwork.com
Background Antidepressant medication prevents the return of depressive symptoms, but
only as long as treatment is continued. Objectives To determine whether cognitive therapy …

STAR* D: revising conventional wisdom

AJ Rush, D Warden, SR Wisniewski, M Fava… - CNS drugs, 2009 - Springer
Abstract The STAR* D (Sequenced Treatment Alternatives to Relieve Depression) study
used a series of sequenced, randomized treatment trials following a first and, if needed …

[HTML][HTML] Medication augmentation after the failure of SSRIs for depression

MH Trivedi, M Fava, SR Wisniewski… - … England Journal of …, 2006 - Mass Medical Soc
Background Although clinicians frequently add a second medication to an initial, ineffective
antidepressant drug, no randomized controlled trial has compared the efficacy of this …

Predictors of attrition during initial (citalopram) treatment for depression: a STAR* D report

D Warden, MH Trivedi, SR Wisniewski… - American Journal of …, 2007 - Am Psychiatric Assoc
Objective: Premature attrition from treatment may lead to worse outcomes and compromise
the integrity of clinical trials in major depressive disorder. The purpose of this study was to …

Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR* D report

SR Wisniewski, AJ Rush… - American Journal of …, 2009 - Am Psychiatric Assoc
Objective: Phase III clinical trials for depression enroll participants with major depressive
disorder according to stringent inclusion and exclusion criteria. These patients may not be …